Metalloproteinase 9 as a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab

被引：1
|
作者：
Zahednasab, Hamid [1 ]
Harirchian, Mohammad Hossein [2 ]
Karampoor, Sajad [3 ]
Keyvani, Hossein [3 ]
机构：
[1] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[2] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Neurol, Iranian Ctr Neurol Res, Tehran, Iran
[3] Iran Univ Med Sci, Sch Med, Dept Virol, Tehran, Iran
来源：
ANNALS OF NEUROLOGY | 2017年 / 82卷 / 04期
关键词：
D O I：
10.1002/ana.25037
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：647 / 647
页数：1
相关论文
共 50 条
  • [1] Matrix Metalloproteinase 9 Is Decreased in Natalizumab-Treated Multiple Sclerosis Patients at Risk for Progressive Multifocal Leukoencephalopathy
    Fissolo, Nicolas
    Pignolet, Beatrice
    Matute-Blanch, Clara
    Trivino, Juan Carlos
    Miro, Berta
    Mota, Miriam
    Perez-Hoyos, Santiago
    Sanchez, Alex
    Vermersch, Patrick
    Ruet, Aurelie
    Vermersch, Patrick
    Ruet, Aurelie
    de Seze, Jerome
    Labauge, Pierre
    Vukusic, Sandra
    Papeix, Caroline
    Almoyna, Laurent
    Tourbah, Ayman
    Clavelou, Pierre
    Moreau, Thibault
    Pelletier, Jean
    Lebrun-Frenay, Christine
    Montalban, Xavier
    Brassat, David
    Comabella, Manuel
    ANNALS OF NEUROLOGY, 2017, 82 (02) : 186 - 195
  • [2] Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis
    Alvarez-Cermeño, JC
    Masjuan, J
    Villar, LM
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16): : 1744 - 1745
  • [3] Progressive Multifocal Leukoencephalopathy with Natalizumab Treatment of Multiple Sclerosis
    Clifford, David B.
    DeLuca, Andrea
    Simpson, David
    Arendt, Gabriele
    Giovannoni, Gavin
    Nath, Avindra
    NEUROLOGY, 2010, 74 (09) : A281 - A282
  • [4] Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis - Reply
    Kleinschmidt-DeMasters, BK
    Tyler, KL
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16): : 1745 - 1745
  • [5] Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy
    Bartt, Russell E.
    CURRENT OPINION IN NEUROLOGY, 2006, 19 (04) : 341 - 349
  • [6] Progressive multifocal leukoencephalopathy and multiple sclerosis: Lessons from natalizumab
    Annette Langer-Gould
    Lawrence Steinman
    Current Neurology and Neuroscience Reports, 2006, 6 : 253 - 258
  • [7] Progressive multifocal leukoencephalopathy and multiple sclerosis: Lessons from natalizumab
    Langer-Gould, Annette
    Steinman, Lawrence
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2006, 6 (03) : 253 - 258
  • [8] Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis
    di Ioia, M.
    Farina, D.
    De Luca, G.
    Travaglini, D.
    Di Tommaso, V.
    Pietrolongo, E.
    Lugaresi, A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S132 - S133
  • [9] Risk stratification for progressive multifocal leukoencephalopathy in multiple sclerosis patients using natalizumab
    Sandrock, A.
    Hotermans, C.
    Richman, S.
    Natarajan, A.
    Lee, S.
    Plavina, T.
    Bloomgren, G.
    Subramanyam, M.
    Bozic, C.
    JOURNAL OF NEUROLOGY, 2011, 258 : 23 - 23
  • [10] Presumptive Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis after Natalizumab Therapy
    Eisele, Philipp
    Szabo, Kristina
    Hornberger, Eva
    Griebe, Martin
    Hennerici, Michael G.
    Kieseier, Bernd C.
    Gass, Achim
    JOURNAL OF NEUROIMAGING, 2014, 24 (04) : 425 - 428
12345